KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Opko Health (OPK) over the last 15 years, with Q2 2025 value amounting to $788.0 million.

  • Opko Health's Shares Outstanding (Diluted Average) rose 1224.59% to $788.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $788.0 million, marking a year-over-year increase of 1224.59%. This contributed to the annual value of $719.1 million for FY2022, which is 1095.29% up from last year.
  • As of Q2 2025, Opko Health's Shares Outstanding (Diluted Average) stood at $788.0 million, which was up 1224.59% from $702.0 million recorded in Q2 2024.
  • Opko Health's 5-year Shares Outstanding (Diluted Average) high stood at $788.0 million for Q2 2025, and its period low was $640.9 million during Q1 2021.
  • In the last 5 years, Opko Health's Shares Outstanding (Diluted Average) had a median value of $702.0 million in 2024 and averaged $697.4 million.
  • Per our database at Business Quant, Opko Health's Shares Outstanding (Diluted Average) soared by 100.19% in 2021 and then soared by 1511.92% in 2022.
  • Opko Health's Shares Outstanding (Diluted Average) (Quarter) stood at $648.1 million in 2021, then rose by 10.95% to $719.1 million in 2022, then increased by 4.51% to $751.5 million in 2023, then decreased by 6.58% to $702.0 million in 2024, then rose by 12.25% to $788.0 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $788.0 million for Q2 2025, versus $702.0 million for Q2 2024 and $751.5 million for Q1 2023.